Key Laboratory of Modern Preparation of Traditional Chinese Medicine, Ministry of Education, Jiangxi University of Chinese Medicine, Nanchang, China.
Department of Pharmacy, Air Force Medical Center, PLA, Beijing, China.
Pharm Dev Technol. 2024 Jul;29(6):551-558. doi: 10.1080/10837450.2024.2361654. Epub 2024 Jun 5.
The purpose of this study was to investigate the impact of different functional stabilizers on drug performances after oral administration of drug nanocrystals. Quercetin nanocrystals (QT-NCs) respectively stabilized by five types of functional stabilizers, including hydroxypropyl methyl cellulose E15 (HPMC E15), poloxamer 407 (P407), poloxamer 188 (P188), D-α-tocopherol polyethylene glycol succinate (TPGS), and glycyrrhizin acid (GL), were fabricated by wet media milling technique. The particle size, morphology, physical state, drug solubility, drug dissolution , and orally pharmacokinetic behaviors of all QT-NCs were investigated. All QT-NCs with similar particle size about 200 nm were obtained by controlling milling speed and milling time. No significant differences in particles shape and crystalline nature were found for QT-NCs stabilized by different functional stabilizers. But the solubility and dissolution of QT-NCs were significantly influenced by the different functional stabilizers. The AUC of all QT-NCs after oral administration was in the following order: QT-NCs/P188 ≈ QT-NCs/HPMC E15 > QT-NCs/GL > QT-NCs/P407 ≈ QT-NCs/TPGS, and the showed an order of QT-NCs/P407 > QT-NCs/P188 ≈ QT-NCs/GL > QT-NCs/HPMC E15 > QT-NCs/TPGS. Both of QT-NCs/P407 and QT-NCs/TPGS exhibited faster oral absorption with at 0.5 h and 0.83 h, respectively, while the other three QT-NCs (QT-NCs/P188, QT-NCs/GL and QT-NCs/HPMC E15) showed a relatively slow absorption with same at 5.33 h. The longest MRT (11.72 h) and (32.22 h) were observed for QT-NCs/HPMC E15. These results suggested that the different functional stabilizers could significantly influence on drug solubility, drug dissolution and orally pharmacokinetic behavior of QT-NCs, and it is possible to alter the drug dissolution , oral absorption and drug retention by changing the type of functional stabilizers in NCs preparation.
本研究旨在探讨不同功能稳定剂对口服给药后药物纳米晶体性能的影响。分别使用羟丙甲纤维素 E15(HPMC E15)、泊洛沙姆 407(P407)、泊洛沙姆 188(P188)、D-α-生育酚聚乙二醇琥珀酸酯(TPGS)和甘草酸(GL)五种类型的功能稳定剂稳定的槲皮素纳米晶体(QT-NCs),通过湿介质研磨技术制备。考察了所有 QT-NCs 的粒径、形态、物理状态、药物溶解度、药物溶出度和口服药代动力学行为。通过控制研磨速度和研磨时间,得到了粒径约为 200nm 的相似的 QT-NCs。用不同功能稳定剂稳定的 QT-NCs 颗粒形状和晶体性质无显著差异。但不同功能稳定剂对 QT-NCs 的溶解度和溶出度有显著影响。口服给药后所有 QT-NCs 的 AUC 顺序为:QT-NCs/P188≈QT-NCs/HPMC E15>QT-NCs/GL>QT-NCs/P407≈QT-NCs/TPGS,QT-NCs/P407 的值大于 QT-NCs/P188、QT-NCs/GL、QT-NCs/HPMC E15、QT-NCs/TPGS。QT-NCs/P407 和 QT-NCs/TPGS 均表现出较快的口服吸收,达峰时间分别为 0.5h 和 0.83h,而另外三种 QT-NCs(QT-NCs/P188、QT-NCs/GL 和 QT-NCs/HPMC E15)则表现出相对较慢的吸收,达峰时间均为 5.33h。QT-NCs/HPMC E15 的 MRT(11.72h)和(32.22h)最长。结果表明,不同功能稳定剂可显著影响 QT-NCs 的药物溶解度、药物溶出度和口服药代动力学行为,通过改变 NCs 制备中功能稳定剂的类型,有可能改变药物溶解、口服吸收和药物滞留。